Panitumumab interaction with TAS-102 leads to combinational anticancer effects via blocking of EGFR-mediated tumor response to trifluridine.
about
Profile of trifluridine/tipiracil hydrochloride in the treatment of metastatic colorectal cancer: efficacy, safety, and place in therapy.Emerging combination therapies for metastatic colorectal cancer - impact of trifluridine/tipiracil.Effects of PHA-665752 and vemurafenib combination treatment on in vitro and murine xenograft growth of human colorectal cancer cells with BRAFV600E mutations.Efficacy and safety of TAS-102 in refractory metastatic colorectal cancer: a meta-analysisEffective Sequential Combined Chemotherapy with Trifluridine/Tipiracil and Regorafenib in Human Colorectal Cancer Cells
P2860
Panitumumab interaction with TAS-102 leads to combinational anticancer effects via blocking of EGFR-mediated tumor response to trifluridine.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Panitumumab interaction with T ...... umor response to trifluridine.
@en
type
label
Panitumumab interaction with T ...... umor response to trifluridine.
@en
prefLabel
Panitumumab interaction with T ...... umor response to trifluridine.
@en
P2093
P2860
P356
P1433
P1476
Panitumumab interaction with T ...... tumor response to trifluridine
@en
P2093
Hiroshi Sawada
Jumpei Soeda
Kazuhide Nakamura
Masamitsu Gotou
Shunsuke Ebara
Toshiya Tamura
Yoshihiko Satoh
P2860
P304
P356
10.1002/1878-0261.12074
P50
P577
2017-05-30T00:00:00Z